Teva Pharma Japan Inc.

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 46,000 people around the world and reached $20.3 billion in net revenues in 2012. 100年以上の歴史と世界中での販売により築いた、ジェネリック世界No.1シェアの実績と信頼を持つTEVAより日本のジェネリックメーカー、テバ製薬が誕生しました。 患者さんのよりよい健康をサポートし、日本でNo.1のジェネリックメーカーを目指します。